Funding for this research was provided by:
National Eye Institute (K23 EY030530-01)
Yale School of Medicine (P30 DK045735)
Doris Duke Charitable Foundation
Research to Prevent Blindness
Article History
Received: 28 March 2022
Revised: 23 June 2022
Accepted: 27 June 2022
First Online: 21 July 2022
Declarations
:
: This study was approved by Yale University’s institutional review board and was carried out in accordance with the Declaration of Helsinki and the Health Insurance Portability and Accountability Act.
: Given the retrospective, chart review nature of this study the Yale University institutional review board found that informed consent could be waived for this study under federal regulation 45 CFR 46.116(d). This part of the regulations states that (1) this research involves no more than minimal risk to the subjects, (2) the waiver or alteration will not adversely affect the rights and welfare of the subjects, (3) the research could not practicably be carried out without the waiver, and (4) whenever appropriate, the subjects will be provided with additional pertinent information after participation.
: Our manuscript does not contain any individual person’s data in any form and therefore consent for publication was not obtained.
: The authors declare no competing interests.
: Its contents are solely the responsibility of the authors and do not necessarily represent the official view of NIH.